CNTNAP5 | Contactin associated protein-like 5 | Predicted membrane proteins
| | | | | Group enriched |
KCNIP2 | Kv channel interacting protein 2 | | | | | | Group enriched |
MBP | Myelin basic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | | | | Tissue enriched |
NRXN1 | Neurexin 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
PRLHR | Prolactin releasing hormone receptor | G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
SLC4A10 | Solute carrier family 4, sodium bicarbonate transporter, member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
STMN4 | Stathmin-like 4 | | | | | | Tissue enriched |
TMEM151A | Transmembrane protein 151A | Predicted membrane proteins
| | | | | Tissue enriched |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CALY | Calcyon neuron-specific vesicular protein | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
CCKBR | Cholecystokinin B receptor | Cancer-related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CDH10 | Cadherin 10, type 2 (T2-cadherin) | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CDH9 | Cadherin 9, type 2 (T1-cadherin) | Predicted membrane proteins
| | | | | Group enriched |
CNTNAP4 | Contactin associated protein-like 4 | Predicted membrane proteins
| | | | | Tissue enriched |
CUX2 | Cut-like homeobox 2 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Group enriched |
ELAVL2 | ELAV like neuron-specific RNA binding protein 2 | | | | | | Group enriched |
FSTL5 | Follistatin-like 5 | Predicted secreted proteins
| | | | | Group enriched |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
SCN2A | Sodium channel, voltage-gated, type II, alpha subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enriched |
SEZ6L | Seizure related 6 homolog (mouse)-like | Predicted membrane proteins
| | | | | Group enriched |
STX1B | Syntaxin 1B | Predicted membrane proteins
| | | | | Tissue enriched |
ARPP21 | CAMP-regulated phosphoprotein, 21kDa | | | | | | Group enriched |
CDH18 | Cadherin 18, type 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GABRB2 | Gamma-aminobutyric acid (GABA) A receptor, beta 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GLRA2 | Glycine receptor, alpha 2 | FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
HRH3 | Histamine receptor H3 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
OPCML | Opioid binding protein/cell adhesion molecule-like | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PPEF1 | Protein phosphatase, EF-hand calcium binding domain 1 | Enzymes Plasma proteins
| | | | | Group enriched |
RBFOX1 | RNA binding protein, fox-1 homolog (C. elegans) 1 | | | | | | Group enriched |
SLC1A2 | Solute carrier family 1 (glial high affinity glutamate transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
APC2 | Adenomatosis polyposis coli 2 | | | | | | Tissue enriched |
CASKIN1 | CASK interacting protein 1 | Plasma proteins
| | | | | Tissue enriched |
DIRAS2 | DIRAS family, GTP-binding RAS-like 2 | | | | | | Tissue enriched |
DKFZP761K2322 | HCG1990367; Putative uncharacterized protein DKFZp761K2322; Putative uncharacterized protein FLJ30594; Uncharacterized protein; cDNA FLJ30594 fis, clone BRAWH2008903 | | | | | | Tissue enriched |
FRMPD4 | FERM and PDZ domain containing 4 | Cytoskeleton related proteins
| | | | | Tissue enriched |
GABBR2 | Gamma-aminobutyric acid (GABA) B receptor, 2 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GABRB1 | Gamma-aminobutyric acid (GABA) A receptor, beta 1 | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
GABRG1 | Gamma-aminobutyric acid (GABA) A receptor, gamma 1 | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
GDAP1L1 | Ganglioside induced differentiation associated protein 1-like 1 | Predicted membrane proteins
| | | | | Tissue enriched |
HAPLN2 | Hyaluronan and proteoglycan link protein 2 | Predicted secreted proteins
| | | | | Tissue enriched |
INA | Internexin neuronal intermediate filament protein, alpha | | | | | | Group enriched |
JPH3 | Junctophilin 3 | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
KCNQ2 | Potassium voltage-gated channel, KQT-like subfamily, member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
KIAA1549L | KIAA1549-like | Predicted membrane proteins
| | | | | Tissue enriched |
LHFPL3 | Lipoma HMGIC fusion partner-like 3 | Predicted membrane proteins
| | | | | Tissue enriched |
MCHR2 | Melanin-concentrating hormone receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
OLFM1 | Olfactomedin 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PDYN | Prodynorphin | Disease related genes Potential drug targets Predicted secreted proteins Transporters
| | | | | Tissue enriched |
SLC5A11 | Solute carrier family 5 (sodium/inositol cotransporter), member 11 | Predicted membrane proteins
| | | | | Group enriched |
TMEM132D | Transmembrane protein 132D | Predicted membrane proteins
| | | | | Tissue enriched |